marketcaparena
Search

    VIR

    Vir Biotechnology, Inc.

    Company overview

    Market capitalization
    $1.78B
    Employees
    367
    Latest publication
    2026-09-29
    About Vir Biotechnology, Inc.

    Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USDQ1 20222022-03-31 · USDQ4 20212021-12-31 · USDQ2 20212021-06-30 · USD
    Total Revenue238,946,000USD-29,000USD64,070,000USD374,557,000USD-40,629,000USD1,232,459,000USD812,747,000USD177,068,000USD
    Cost Of Revenue0USD2,811,000USD-366,561,000USD136,419,000USD143,003,000USD180,376,000USD185,218,000USD87,270,000USD
    Gross Profit238,946,000USD-2,840,000USD430,631,000USD238,138,000USD-183,632,000USD1,052,083,000USD627,529,000USD89,798,000USD
    Research Development135,283,000USD108,922,000USD88,349,000USD114,166,000USD115,082,000USD90,227,000USD128,341,000USD86,126,000USD
    Selling General Administrative30,196,000USD23,339,000USD23,616,000USD43,174,000USD41,590,000USD38,255,000USD25,739,000USD28,781,000USD
    Total Operating Expenses165,479,000USD130,340,000USD467,244,000USD43,174,000USD41,590,000USD38,255,000USD55,777,000USD28,781,000USD
    Operating Income73,467,000USD-133,180,000USD-36,613,000USD194,964,000USD-225,222,000USD1,013,828,000USD571,752,000USD61,017,000USD
    Total Other Income Expense Net6,792,000USD7,655,000USD-6,447,000USD22,768,000USD-8,499,000USD-91,921,000USD-25,863,000USD849,000USD
    Interest Income8,966,000USD7,189,000USD7,802,000USD9,332,000USD2,200,000USD388,000USD167,000USD97,000USD
    Income Before Tax80,259,000USD-125,525,000USD-43,060,000USD217,732,000USD-233,721,000USD921,907,000USD545,889,000USD61,866,000USD
    Income Tax Expense179,000USD170,000USD-137,000USD42,420,000USD-157,228,000USD403,286,000USD20,635,000USD53,000USD
    Net Income80,080,000USD-125,695,000USD-42,923,000USD175,312,000USD-76,493,000USD518,621,000USD525,254,000USD61,813,000USD
    Unclassified Operating Expenses—-1,921,000USD254,596,000USD-114,166,000USD-115,082,000USD-90,227,000USD-98,303,000USD-86,126,000USD
    Net Interest Income—7,189,000USD7,802,000USD9,332,000USD2,200,000USD388,000USD167,000USD97,000USD
    Tax Provision—170,000USD-137,000USD42,420,000USD-157,228,000USD403,286,000USD20,635,000USD53,000USD
    Net Income From Continuing Ops—-125,695,000USD-42,923,000USD175,312,000USD-76,493,000USD518,621,000USD525,254,000USD61,813,000USD
    Ebit—-125,525,000USD-43,060,000USD217,732,000USD-233,721,000USD921,907,000USD611,152,000USD61,866,000USD
    Ebitda—-122,714,000USD-40,162,000USD219,414,000USD-232,125,000USD923,459,000USD612,673,000USD63,401,000USD
    Depreciation And Amortization—2,811,000USD2,898,000USD1,682,000USD1,596,000USD1,552,000USD1,521,000USD1,535,000USD
    Reconciled Depreciation—2,811,000USD2,898,000USD1,682,000USD1,596,000USD1,552,000USD1,521,000USD1,402,000USD
    Other Operating Expenses——100,683,000USD—————
    Interest Expense———9,332,000USD19,889,000USD388,000USD——
    Non Operating Income Net Other———22,768,000USD-8,499,000USD-91,921,000USD-25,863,000USD849,000USD
    Net Income Applicable To Common Shares———175,312,000USD-76,493,000USD518,621,000USD525,254,000USD61,813,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Total Revenue1,615,797,000USD1,095,415,000USD76,368,000USD711,000USD868,000USD149,000USD
    Cost Of Revenue620,967,000USD513,871,000USD301,579,000USD143,072,000USD100,229,000USD62,512,000USD
    Gross Profit994,830,000USD581,544,000USD76,368,000USD711,000USD-99,361,000USD-62,363,000USD
    Research Development474,648,000USD448,006,000USD302,411,000USD148,472,000USD100,229,000USD62,512,000USD
    Selling General Administrative161,762,000USD160,793,000USD70,937,000USD37,598,000USD29,131,000USD21,693,000USD
    Unclassified Operating Expenses-474,648,000USD-448,006,000USD—-7,380,000USD-9,800,000USD-2,559,000USD
    Total Operating Expenses161,762,000USD160,793,000USD373,348,000USD178,690,000USD119,560,000USD81,646,000USD
    Operating Income833,068,000USD420,751,000USD-296,980,000USD-177,979,000USD-118,692,000USD-81,497,000USD
    Interest Income28,092,000USD439,000USD2,836,000USD8,511,000USD2,540,000USD638,000USD
    Interest Expense183,145,000USD272,911,000USD3,811,000USD7,967,000USD0USD0USD
    Net Interest Income28,092,000USD439,000USD2,836,000USD8,511,000USD2,540,000USD638,000USD
    Income Before Tax754,280,000USD549,802,000USD-298,611,000USD-174,529,000USD-116,364,000USD-80,776,000USD
    Income Tax Expense238,443,000USD21,218,000USD-54,000USD154,000USD-480,000USD-10,924,000USD
    Tax Provision238,443,000USD21,218,000USD54,000USD154,000USD-480,000USD-10,924,000USD
    Net Income515,837,000USD528,583,999USD-298,665,000USD-174,683,000USD-115,884,000USD-69,852,000USD
    Net Income From Continuing Ops515,837,000USD528,584,000USD-298,665,000USD-174,683,000USD-115,884,000USD-69,852,000USD
    Ebit754,280,000USD549,802,000USD-298,719,000USD-177,979,000USD-118,692,000USD-81,497,000USD
    Ebitda761,063,000USD555,613,000USD514,328,100USD-173,462,000USD-115,936,000USD-81,065,000USD
    Depreciation And Amortization6,783,000USD5,811,000USD5,442,000USD4,517,000USD2,756,000USD432,000USD
    Reconciled Depreciation6,783,000USD5,811,000USD5,442,000USD4,517,000USD2,756,000USD432,000USD
    Total Other Income Expense Net-78,788,000USD129,051,000USD296,681,389USD3,450,000USD2,328,000USD721,000USD
    Minority Interest0USD0USD——0USD0USD
    Net Income Applicable To Common Shares515,837,000USD528,584,000USD-298,665,000USD-174,683,000USD-115,884,000USD-69,852,000USD
    Non Operating Income Net Other—129,051,000USD-1,631,000USD—0USD0USD
    Discontinued Operations————0USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,214,806,000USD1,025,585,000USD1,002,823,000USD1,019,453,000USD1,192,532,000USD1,307,727,000USD1,398,813,000USD1,498,356,000USD
    Cash And Equivalents278,729,000USD———————
    Cash And Short Term Investments528,593,000USD472,363,000USD462,860,000USD506,513,000USD606,019,000USD801,662,000USD905,348,000USD914,474,000USD
    Short Term Investments249,864,000USD196,277,000USD228,753,000USD336,429,000USD394,915,000USD528,091,000USD682,401,000USD746,124,000USD
    Long Term Investments475,016,000USD332,970,000USD314,575,000USD304,212,000USD286,099,000USD218,140,000USD190,015,000USD271,495,000USD
    Total Current Assets573,739,000USD522,985,000USD514,080,000USD545,684,000USD735,706,000USD932,207,000USD1,042,458,000USD1,047,157,000USD
    Other Current Assets39,084,000USD50,622,000USD47,620,000USD39,171,000USD129,687,000USD130,545,000USD132,010,000USD132,683,000USD
    Total Liabilities232,313,000USD———————
    Total Current Liabilities94,961,000USD73,558,000USD92,815,000USD75,222,000USD105,004,000USD137,286,000USD119,662,000USD117,161,000USD
    Other Non Current Liabilities18,875,000USD———————
    Total Equity Including Noncontrolling Interest982,493,000USD———————
    Property Plant Equipment Net109,821,000USD113,918,000USD117,719,000USD121,758,000USD125,648,000USD120,240,000USD122,863,000USD125,570,000USD
    Goodwill16,937,000USD———————
    Intangible Assets7,702,000USD7,777,000USD7,850,000USD7,924,000USD7,998,000USD8,072,000USD8,098,000USD19,258,000USD
    Accounts Payable17,754,000USD5,445,000USD9,803,000USD6,847,000USD12,234,000USD3,725,000USD5,081,000USD7,305,000USD
    Common Stock17,000USD16,000USD14,000USD14,000USD14,000USD14,000USD14,000USD14,000USD
    Retained Earnings-1,243,386,000USD-1,323,466,000USD-1,197,771,000USD-1,154,848,000USD-991,707,000USD-880,749,000USD-759,784,000USD-655,195,000USD
    Accumulated Other Comprehensive Income-4,602,000USD-3,483,000USD-2,057,000USD-1,911,000USD-2,221,000USD-1,975,000USD-1,717,000USD1,127,000USD
    Total Liab—212,820,000USD237,547,000USD223,355,000USD245,060,000USD263,908,000USD248,428,000USD257,629,000USD
    Total Stockholder Equity—812,765,000USD765,276,000USD796,098,000USD947,472,000USD1,043,819,000USD1,150,385,000USD1,240,727,000USD
    Other Current Liab—59,169,000USD74,214,000USD59,415,000USD73,836,000USD113,701,000USD94,181,000USD75,250,000USD
    Capital Stock—16,000USD14,000USD14,000USD14,000USD14,000USD14,000USD14,000USD
    Good Will—16,937,000USD16,937,000USD16,937,000USD16,937,000USD16,937,000USD16,937,000USD16,938,000USD
    Cash—276,086,000USD234,107,000USD170,084,000USD211,104,000USD273,571,000USD222,947,000USD168,350,000USD
    Net Debt—-180,507,000USD-47,201,000USD-69,909,000USD-108,874,000USD-177,476,000USD-125,056,000USD-55,537,000USD
    Short Term Debt—8,944,000USD8,798,000USD8,960,000USD8,825,000USD7,925,000USD7,752,000USD19,408,000USD
    Short Long Term Debt Total—95,579,000USD186,906,000USD100,175,000USD102,230,000USD96,095,000USD97,891,000USD112,813,000USD
    Property Plant Equipment Gross—163,816,000USD164,879,000USD166,246,000USD167,211,000USD159,110,000USD159,648,000USD160,763,000USD
    Common Stock Shares Outstanding—147,356,811shares139,232,143shares138,930,173shares138,447,000shares137,469,000shares136,809,000shares136,654,000shares
    Non Current Assets Total—502,600,000USD488,743,000USD473,769,000USD456,826,000USD375,520,000USD356,333,000USD451,199,000USD
    Non Current Liabilities Total—139,262,000USD144,732,000USD148,133,000USD140,056,000USD126,622,000USD128,766,000USD140,468,000USD
    Non Current Liabilities Other—52,627,000USD55,678,000USD47,485,000USD46,651,000USD38,452,000USD38,627,000USD47,063,000USD
    Non Currrent Assets Other—30,998,000USD31,662,000USD22,938,000USD20,144,000USD12,131,000USD18,420,000USD17,938,000USD
    Net Working Capital—449,427,000USD421,265,000USD470,462,000USD630,702,000USD794,921,000USD922,796,000USD929,996,000USD
    Unclassified Non Current Liabilities—86,635,000USD89,054,000USD100,648,000USD93,405,000USD88,170,000USD90,139,000USD93,405,000USD
    Unclassified Equity—2,139,682,000USD1,965,076,000USD1,952,829,000USD1,941,372,000USD1,926,515,000USD1,911,858,000USD1,894,767,000USD
    Net Receivables——3,600,000USD4,000,000USD5,200,000USD—5,100,000USD5,300,000USD
    Current Deferred Revenue———9,433,000USD10,109,000USD11,935,000USD12,648,000USD15,198,000USD
    Unclassified Current Liabilities———-9,433,000USD————
    Other Assets——————22,000USD1USD
    Inventory———————-5,300,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,002,823,000USD1,398,813,000USD1,919,060,000USD2,802,088,000USD1,954,268,000USD918,761,000USD512,071,000USD191,596,000USD
    Intangible Assets7,850,000USD8,098,000USD22,565,000USD32,755,000USD33,287,000USD33,820,000USD35,694,000USD36,917,000USD
    Other Current Assets47,620,000USD137,110,000USD65,817,000USD117,037,000USD81,597,000USD35,504,000USD13,378,000USD19,340,000USD
    Total Liab237,547,000USD248,428,000USD328,824,000USD724,125,000USD522,419,000USD201,909,000USD88,129,000USD370,773,000USD
    Total Stockholder Equity765,276,000USD1,150,385,000USD1,590,236,000USD2,077,963,000USD1,431,849,000USD716,852,000USD423,942,000USD-179,177,000USD
    Other Current Liab74,214,000USD94,181,000USD91,204,000USD469,725,000USD226,368,000USD83,911,000USD46,907,000USD24,674,000USD
    Common Stock14,000USD14,000USD13,000USD13,000USD13,000USD13,000USD11,000USD1,000USD
    Capital Stock14,000USD14,000USD13,000USD13,000USD13,000USD13,000USD11,000USD1,000USD
    Retained Earnings-1,197,771,000USD-759,784,000USD-237,824,000USD377,237,000USD-138,600,000USD-667,184,000USD-368,519,000USD-193,836,000USD
    Good Will16,937,000USD16,937,000USD16,937,000USD16,937,000USD16,937,000USD16,937,000USD16,937,000USD16,937,000USD
    Cash234,107,000USD222,947,000USD241,576,000USD848,631,000USD347,815,000USD436,575,000USD109,335,000USD47,598,000USD
    Cash And Short Term Investments462,860,000USD905,348,000USD1,522,409,000USD2,402,040,000USD708,145,000USD736,861,000USD383,436,000USD98,443,000USD
    Total Current Assets514,080,000USD1,042,458,000USD1,588,226,000USD2,519,077,000USD1,562,821,000USD772,365,000USD402,995,000USD117,783,000USD
    Total Current Liabilities92,815,000USD119,662,000USD175,407,000USD511,029,000USD341,242,000USD99,064,000USD59,206,000USD39,908,000USD
    Net Debt-47,201,000USD-125,056,000USD-117,036,000USD-720,657,000USD-210,327,000USD-366,394,000USD-109,098,000USD-37,458,000USD
    Short Term Debt8,798,000USD7,752,000USD12,867,000USD4,137,000USD3,927,000USD3,625,000USD237,000USD14,534,000USD
    Short Long Term Debt Total186,906,000USD97,891,000USD124,540,000USD127,974,000USD137,488,000USD70,181,000USD1,137,000USD10,140,000USD
    Long Term Investments314,575,000USD190,015,000USD105,275,000USD23,927,000USD201,388,000USD0USD24,290,000USD6,600,000USD
    Short Term Investments228,753,000USD682,401,000USD1,280,833,000USD1,553,409,000USD360,330,000USD300,286,000USD274,101,000USD50,845,000USD
    Net Receivables3,600,000USD5,100,000USD11,600,000USD26,400,000USD773,079,000USD1,900,000USD——
    Accounts Payable9,803,000USD5,081,000USD6,334,000USD6,422,000USD6,521,000USD5,077,000USD5,881,000USD6,473,000USD
    Property Plant Equipment Net117,719,000USD122,863,000USD167,200,000USD188,166,000USD130,054,000USD79,893,000USD16,308,000USD12,290,000USD
    Property Plant Equipment Gross164,879,000USD159,648,000USD201,096,000USD188,166,000USD130,054,000USD17,946,000USD16,308,000USD12,290,000USD
    Accumulated Other Comprehensive Income-2,057,000USD-1,717,000USD-815,000USD-9,122,000USD-1,099,000USD-1,278,000USD-601,000USD-14,000USD
    Common Stock Shares Outstanding138,520,419shares136,247,000shares134,130,924shares134,810,908shares133,437,126shares119,159,424shares107,648,925shares96,912,507shares
    Non Current Assets Total488,743,000USD356,333,000USD330,834,000USD283,011,000USD391,447,000USD146,396,000USD109,076,000USD73,813,000USD
    Non Current Liabilities Total144,732,000USD128,766,000USD153,417,000USD213,096,000USD181,177,000USD102,845,000USD28,923,000USD330,865,000USD
    Non Current Liabilities Other55,678,000USD38,627,000USD40,218,000USD32,799,000USD25,362,000USD95,777,000USD12,948,000USD10,838,000USD
    Non Currrent Assets Other31,662,000USD18,420,000USD18,857,000USD-228,498,000USD9,781,000USD15,746,000USD15,847,000USD7,669,000USD
    Net Working Capital421,265,000USD922,796,000USD1,412,819,000USD2,008,048,000USD1,221,579,000USD673,301,000USD343,789,000USD77,875,000USD
    Unclassified Non Current Liabilities89,054,000USD90,139,000USD113,199,000USD91,038,000USD85,945,000USD-36,289,000USD-12,948,000USD299,323,000USD
    Unclassified Equity1,965,076,000USD1,911,858,000USD1,828,849,000USD1,709,822,000USD1,571,522,000USD1,385,288,000USD793,040,000USD14,671,000USD
    Other Assets—22,000USD1USD21,226,000USD9,781,000USD77,693,000USD9,247,000USD1,069,000USD
    Current Deferred Revenue—12,648,000USD64,853,000USD15,517,000USD98,209,000USD6,451,000USD6,181,000USD8,761,000USD
    Other Liab———89,259,000USD47,616,000USD36,289,000USD28,923,000USD20,704,000USD
    Net Tangible Assets———2,028,271,000USD1,381,625,000USD666,095,000USD371,311,000USD-233,031,000USD
    Unclassified Current Assets———-26,400,000USD——6,181,000USD—
    Unclassified Current Liabilities———15,228,000USD6,217,000USD——-14,534,000USD
    Deferred Long Term Liab————22,254,000USD7,068,000USD—0USD
    Inventory————8,594,000USD——0USD
    Unclassified Non Current Assets————-9,781,000USD-77,693,000USD-9,247,000USD-7,669,000USD
    Short Long Term Debt———————0USD
    Long Term Debt———————0USD
    Accumulated Depreciation———————0USD
    Additional Paid In Capital———————0USD
    Treasury Stock———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-125,695,000USD-42,923,000USD-163,141,000USD-110,958,000USD-120,965,000USD-104,589,000USD-213,717,000USD-138,378,000USD
    Depreciation2,811,000USD2,898,000USD2,998,000USD9,527,000USD2,867,000USD2,886,000USD2,896,000USD4,260,000USD
    Stock Based Compensation12,087,000USD22,562,000USD11,356,000USD12,451,000USD14,059,000USD15,841,000USD16,697,000USD22,162,000USD
    Other Non Cash Items13,181,000USD-5,569,000USD13,174,000USD-6,178,000USD-136,000USD17,871,000USD21,791,000USD58,986,000USD
    Change In Working Capital-22,683,000USD-2,844,000USD-20,601,000USD-25,061,000USD26,059,000USD-17,001,000USD17,493,000USD-2,352,000USD
    Total Cash From Operating Activities-132,386,000USD-25,876,000USD-167,570,000USD-120,219,000USD-78,116,000USD-87,635,000USD-171,480,000USD-77,847,000USD
    Capital Expenditures-390,000USD4,484,000USD-317,000USD-2,538,000USD-1,629,000USD-2,407,000USD-2,356,000USD-666,000USD
    Free Cash Flow-132,776,000USD-21,392,000USD-167,887,000USD-122,757,000USD-79,745,000USD-90,042,000USD-173,836,000USD-78,513,000USD
    Investments12,225,000USD87,109,000USD40,446,000USD56,456,000USD126,818,000USD140,737,000USD118,603,000USD211,607,000USD
    Total Cashflows From Investing Activities11,835,000USD86,651,000USD40,446,000USD56,456,000USD126,818,000USD140,737,000USD118,603,000USD211,607,000USD
    Total Cash From Financing Activities162,523,000USD1,039,000USD102,000USD2,046,000USD598,000USD1,263,000USD31,000USD2,942,000USD
    Issuance Of Capital Stock162,349,000USD———0USD———
    Change In Cash41,979,000USD61,808,000USD-127,023,000USD-61,717,000USD49,300,000USD54,365,000USD-52,862,001USD136,764,000USD
    Begin Period Cash Flow234,107,000USD172,299,000USD299,322,000USD367,995,000USD318,695,000USD264,330,000USD310,810,000USD174,046,000USD
    End Period Cash Flow276,086,000USD234,107,000USD172,299,000USD306,278,000USD367,995,000USD318,695,000USD257,947,999USD310,810,000USD
    Unclassified Operating Cash Flow-12,087,000USD—-11,356,000USD——-2,643,000USD-16,640,000USD-22,525,000USD
    Other Cashflows From Investing Activities—-4,905,000USD-4,447,000USD45,000USD281,000USD2,867,000USD-412,000USD212,273,000USD
    Other Cashflows From Financing Activities—359,000USD1,000USD-360,000USD598,000USD1,263,000USD71,000USD3,011,000USD
    Unclassified Investing Cash Flow——4,764,000USD2,493,000USD1,348,000USD—2,768,000USD-211,607,000USD
    Unclassified Financing Cash Flow———2,406,000USD————
    Net Borrowings————0USD—-40,000USD—
    Change To Account Receivables—————-8,747,000USD-54,000USD2,689,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-437,987,000USD-521,960,000USD-615,061,000USD515,837,000USD528,584,000USD-298,665,000USD-174,683,000USD-115,884,000USD
    Depreciation21,154,000USD14,559,000USD19,451,000USD6,783,000USD5,811,000USD5,442,000USD4,517,000USD2,756,000USD
    Stock Based Compensation49,072,000USD78,457,000USD111,316,000USD102,082,000USD83,784,000USD27,600,000USD8,719,000USD5,053,000USD
    Other Non Cash Items-1,573,000USD69,548,000USD122,479,000USD388,370,000USD-52,560,000USD45,212,000USD23,611,000USD1,965,000USD
    Change In Working Capital-22,447,000USD-84,007,000USD-304,591,000USD665,367,000USD-628,394,000USD29,522,000USD8,204,000USD12,494,000USD
    Total Cash From Operating Activities-391,781,000USD-446,352,000USD-778,785,000USD1,663,253,000USD-47,589,000USD-190,941,000USD-129,632,000USD-94,096,000USD
    Capital Expenditures-4,832,000USD-7,301,000USD-21,573,000USD-68,006,000USD-21,817,000USD-6,549,000USD-8,940,000USD-8,192,000USD
    Free Cash Flow-396,613,000USD-453,653,000USD-800,358,000USD1,595,247,000USD-69,406,000USD-197,490,000USD-138,572,000USD-102,288,000USD
    Investments314,950,000USD499,367,000USD116,305,000USD-1,193,461,000USD-118,997,000USD-3,493,000USD-256,158,000USD-60,441,000USD
    Total Cashflows From Investing Activities310,371,000USD499,367,000USD164,729,000USD-1,193,461,000USD-140,814,000USD-9,862,000USD-256,158,000USD-60,441,000USD
    Total Cash From Financing Activities3,785,000USD4,388,000USD7,380,000USD34,761,000USD100,331,000USD529,474,000USD449,244,000USD24,978,000USD
    Change In Cash-77,625,000USD57,403,000USD-606,468,000USD504,553,000USD-88,072,000USD328,671,000USD63,454,000USD-129,559,000USD
    Begin Period Cash Flow318,695,000USD261,292,000USD861,312,000USD363,415,000USD451,487,000USD122,816,000USD59,362,000USD188,921,000USD
    End Period Cash Flow241,070,000USD318,695,000USD254,844,000USD867,968,000USD363,415,000USD451,487,000USD122,816,000USD59,362,000USD
    Other Cashflows From Investing Activities-4,579,000USD3,372,000USD—-1,125,455,000USD-140,814,000USD180,000USD-247,218,000USD-1,743,000USD
    Other Cashflows From Financing Activities3,785,000USD4,388,000USD-100,000USD6,559,000USD15,377,000USD-189,000USD318,464,000USD24,978,000USD
    Unclassified Investing Cash Flow4,832,000USD—69,997,000USD1,193,461,000USD140,814,000USD—256,158,000USD9,935,000USD
    Change To Account Receivables—-6,513,000USD-565,000USD770,038,000USD-773,079,000USD-773,079,000USD-773,079,000USD-773,079,000USD
    Issuance Of Capital Stock—0USD0USD28,462,000USD85,213,000USD529,913,000USD443,746,000USD24,394,000USD
    Net Borrowings——-287,000USD-260,000USD-259,000USD-250,000USD1,107,000USD1,107,000USD
    Unclassified Operating Cash Flow——-112,379,000USD—15,186,000USD———
    Unclassified Financing Cash Flow——7,767,000USD25,240,000USD69,836,000USD202,640,000USD129,676,000USD-15,945,000USD
    Change To Liabilities———-32,503,000USD91,870,000USD38,781,000USD4,493,000USD9,344,000USD
    Sale Purchase Of Stock———3,222,000USD15,377,000USD327,273,000USD-3,000USD14,838,000USD
    Change To Inventory————52,815,000USD——0USD
    Cash And Cash Equivalents Changes————-88,072,000USD328,671,000USD—0USD
    Dividends Paid———————0USD
    Exchange Rate Changes———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductGrant11,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductLicense And Collaboration Revenue238,935,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductOther Revenue0USDDisclosure
    FY 2025Yearly · 2025-12-31GeographyInternational66,520,000USD0001628280-26-010749
    FY 2025Yearly · 2025-12-31GeographyUnited States2,036,000USD0001628280-26-010749
    Q4 2025Quarterly · 2025-12-31GeographyInternational63,760,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States310,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductGrant2,036,000USD0001628280-26-010749
    FY 2025Yearly · 2025-12-31ProductLicense And Collaboration Revenue63,130,000USD0001628280-26-010749
    FY 2025Yearly · 2025-12-31ProductOther Revenue3,390,000USD0001628280-26-010749
    Q3 2025Quarterly · 2025-09-30ProductCollaboration Revenue-65,000USD0001628280-25-049694
    Q3 2025Quarterly · 2025-09-30ProductContract Revenue0USD0001628280-25-049694
    Q3 2025Quarterly · 2025-09-30ProductGrant305,000USD0001628280-25-049694
    Q3 2025Quarterly · 2025-09-30GeographyInternational-65,000USD0001628280-25-049694
    Q3 2025Quarterly · 2025-09-30GeographyUnited States305,000USD0001628280-25-049694
    Q2 2025Quarterly · 2025-06-30ProductCollaboration Revenue-495,000USD0001628280-25-038431
    Q2 2025Quarterly · 2025-06-30ProductContract Revenue1,526,000USD0001628280-25-038431
    Q2 2025Quarterly · 2025-06-30ProductGrant183,000USD0001628280-25-038431
    Q2 2025Quarterly · 2025-06-30GeographyInternational1,031,000USD0001628280-25-038431
    Q2 2025Quarterly · 2025-06-30GeographyUnited States183,000USD0001628280-25-038431
    Q1 2025Quarterly · 2025-03-31ProductGrant1,238,000USD0001628280-26-031471
    Q1 2025Quarterly · 2025-03-31ProductLicense And Collaboration Revenue-70,000USD0001628280-26-031471
    Q1 2025Quarterly · 2025-03-31ProductOther Revenue1,864,000USD0001628280-26-031471
    Q1 2025Quarterly · 2025-03-31GeographyInternational1,794,000USD0001628280-25-023291
    Q1 2025Quarterly · 2025-03-31GeographyUnited States1,238,000USD0001628280-25-023291
    Q4 2024Quarterly · 2024-12-31ProductCollaboration Revenue10,413,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductContract Revenue865,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductGrant1,096,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational62,680,000USD0001628280-26-010749
    FY 2024Yearly · 2024-12-31GeographyUnited States11,525,000USD0001628280-26-010749
    Q4 2024Quarterly · 2024-12-31GeographyInternational10,601,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States1,773,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductCollaboration Revenue8,379,000USD0001628280-25-008245
    FY 2024Yearly · 2024-12-31ProductContract Revenue55,333,000USD0001628280-25-008245
    FY 2024Yearly · 2024-12-31ProductGrant10,493,000USD0001628280-25-008245
    FY 2024Yearly · 2024-12-31ProductLicense Revenue0USD0001628280-25-008245
    Q3 2024Quarterly · 2024-09-30ProductCollaboration Revenue-1,102,000USD0001628280-25-049694
    Q3 2024Quarterly · 2024-09-30ProductContract Revenue1,391,000USD0001628280-25-049694
    Q3 2024Quarterly · 2024-09-30ProductGrant2,091,000USD0001628280-25-049694
    Q3 2024Quarterly · 2024-09-30GeographyInternational289,000USD0001628280-25-049694
    Q3 2024Quarterly · 2024-09-30GeographyUnited States2,091,000USD0001628280-25-049694
    Q2 2024Quarterly · 2024-06-30ProductCollaboration Revenue55,000USD0001628280-25-038431
    Q2 2024Quarterly · 2024-06-30ProductContract Revenue886,000USD0001628280-25-038431
    Q2 2024Quarterly · 2024-06-30ProductGrant2,134,000USD0001628280-25-038431
    Q2 2024Quarterly · 2024-06-30GeographyInternational586,000USD0001628280-25-038431
    Q2 2024Quarterly · 2024-06-30GeographyUnited States2,489,000USD0001628280-25-038431
    Q1 2024Quarterly · 2024-03-31ProductCollaboration Revenue-987,000USD0001628280-25-023291
    Q1 2024Quarterly · 2024-03-31ProductContract Revenue52,191,000USD0001628280-25-023291
    Q1 2024Quarterly · 2024-03-31ProductGrant5,172,000USD0001628280-25-023291
    Q1 2024Quarterly · 2024-03-31GeographyInternational51,204,000USD0001628280-25-023291
    Q1 2024Quarterly · 2024-03-31GeographyUnited States5,172,000USD0001628280-25-023291
    FY 2023Yearly · 2023-12-31GeographyInternational39,042,000USD0001628280-26-010749
    FY 2023Yearly · 2023-12-31GeographyUnited States47,138,000USD0001628280-26-010749
    FY 2023Yearly · 2023-12-31ProductCollaboration Revenue37,266,000USD0001628280-25-008245
    FY 2023Yearly · 2023-12-31ProductContract Revenue2,228,000USD0001628280-25-008245
    FY 2023Yearly · 2023-12-31ProductGrant46,686,000USD0001628280-25-008245
    FY 2023Yearly · 2023-12-31ProductLicense Revenue0USD0001628280-25-008245
    FY 2022Yearly · 2022-12-31GeographyInternational1,576,098,000USD0001628280-25-008245
    FY 2022Yearly · 2022-12-31GeographyUnited States39,699,000USD0001628280-25-008245
    FY 2022Yearly · 2022-12-31ProductCollaboration Revenue — Profit Sharing Amount1,875,147,000USD0001628280-25-008245
    FY 2022Yearly · 2022-12-31ProductCollaboration Revenue — Profit Sharing Amount Constrained-369,678,000USD0001628280-25-008245
    FY 2022Yearly · 2022-12-31ProductOther110,328,000USD0001628280-25-008245
    FY 2022Yearly · 2022-12-31ProductProfit Sharing Amount Previously Constrained Released0USD0001628280-25-008245
    FY 2021Yearly · 2021-12-31ProductBiological Materials400,000USD0000950170-22-002295
    FY 2021Yearly · 2021-12-31ProductCollaboration Revenue917,194,000USD0000950170-22-002295
    FY 2021Yearly · 2021-12-31ProductContract Revenue169,874,000USD0000950170-22-002295
    FY 2021Yearly · 2021-12-31ProductLicense0USD0000950170-22-002295
    FY 2021Yearly · 2021-12-31ProductOther7,947,000USD0000950170-22-002295
    FY 2020Yearly · 2020-12-31ProductBiological Materials0USD0000950170-22-002295
    FY 2020Yearly · 2020-12-31ProductCollaboration Revenue0USD0000950170-22-002295
    FY 2020Yearly · 2020-12-31ProductContract Revenue44,498,000USD0000950170-22-002295
    FY 2020Yearly · 2020-12-31ProductLicense22,747,000USD0000950170-22-002295
    FY 2020Yearly · 2020-12-31ProductOther9,123,000USD0000950170-22-002295

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.